Equities

Sincere Co Ltd

7782:TYO

Sincere Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)506.00
  • Today's Change-3.00 / -0.59%
  • Shares traded8.90k
  • 1 Year change-6.30%
  • Beta1.8242
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,1941,1331,088
Total Receivables, Net1,086920859
Total Inventory1,057917868
Prepaid expenses--7330
Other current assets, total596308321
Total current assets4,9333,3513,164
Property, plant & equipment, net573137
Goodwill, net33341--
Intangibles, net148.527.69
Long term investments--00
Note receivable - long term------
Other long term assets494775
Total assets5,4003,5773,290
LIABILITIES
Accounts payable14272179
Accrued expenses12129.64
Notes payable/short-term debt1,300350200
Current portion long-term debt/capital leases220208140
Other current liabilities, total444322263
Total current liabilities2,118964791
Total long term debt779539395
Total debt2,2991,097735
Deferred income tax------
Minority interest73----
Other liabilities, total198763
Total liabilities2,9901,5891,249
SHAREHOLDERS EQUITY
Common stock273273273
Additional paid-in capital317321326
Retained earnings (accumulated deficit)2,0311,7611,768
Treasury stock - common(323)(352)(374)
Unrealized gain (loss)------
Other equity, total111(16)47
Total equity2,4101,9882,040
Total liabilities & shareholders' equity5,4003,5773,290
Total common shares outstanding6.346.306.27
Treasury shares - common primary issue0.520.560.59
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.